Skip to main content
logo
Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.7350
-0.0650 (-8.13%)
At close: Aug 17, 2026, 4:00 PM EDT
0.6938
-0.0412 (-5.61%)
Pre-market: Aug 18, 2026, 4:02 AM EDT

Envoy Medical Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.210.240.230.320.240.31
Revenue Growth
-6.76%7.11%-28.80%33.33%-23.55%-
Gross Profit
-0.61-0.44-0.52-0.47-0.26-0.46
Operating Income
-23.43-22.08-19.26-18.36-8.71-6.87
Net Income
-28.46-28.66-27.97-31.27-15.92-8.68
Earnings Per Share
-0.51-1.23-1.49-2.54-1.57-0.86
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.683.745.484.220.181.12
Total Debt
0.810.9219.660.5634.5423.48
Net Cash (Debt)
18.872.82-14.183.66-34.35-22.36
Net Cash Growth
------
Net Cash Per Share
0.340.12-0.750.30-3.39-2.21

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-21.53-18.2-17.95-17.09-8.81-6.94
Capital Expenditures
-0.18-0.18-0.98-0.15-0.22-0.13
Free Cash Flow
-21.71-18.38-18.93-17.24-9.02-7.06
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-293.72%-183.82%-229.78%-149.68%-110.13%-148.06%
Operating Margin
-11319.32%-9161.83%-8558.22%-5809.81%-3673.42%-2216.45%
Pretax Margin
-11304.83%-9857.26%-9242.22%-9468.99%-6718.57%-2798.39%
Profit Margin
-13747.34%-11892.95%-12432.44%-9895.89%-6718.56%-2798.39%
FCF Margin
-10488.41%-7626.56%-8412.89%-5456.96%-3807.17%-2277.74%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
274.1078.97128.67112.02--